Although CD20+ T cells have been observed in peripheral blood and tissues from patients with different diseases, including cancer and autoimmune disorders, the mechanisms underlying their presence and their potential pathogenic implications remain poorly understood. This evidence concerns the gene MS4A1 and autoimmune disease.